Jeffrey Chodakewitz Insider Trading $VRTX VERTEX PHARMACEUTICALS INC / MA
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jeffrey Chodakewitz.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jeffrey Chodakewitz. Jeffrey Chodakewitz is EVP GMDA, CMO in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and Director in TETRAPHASE PHARMACEUTICALS INC ($TTPH) and Director in Schrodinger, Inc. ($SDGR) and Director in Praxis Precision Medicines, Inc. ($PRAX) and Director in resTORbio, Inc. ($TORC).
Jeffrey Chodakewitz in VERTEX PHARMACEUTICALS INC / MA
Trading Symbol: VRTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey Chodakewitz: EVP GMDA, CMO
Holdings: 64,660 shares
Current Value: $5,615,074
Latest Transaction: Feb 08 2018
$VRTX Market Capitalization: $21.78B
$VRTX Previous Close: $86.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jeffrey Chodakewitz in VERTEX PHARMACEUTICALS INC / MA
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, TORC, PRAX, SDGR, TTPH, VRTX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 08 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | A | 155.57 | 23,479 | 3,652,628 | 23,479 | |
Feb 08 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Grant | A | 0.00 | 10,125 | 0 | 74,785 | 64.7 K to 74.8 K (+15.66 %) |
Feb 08 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Grant | A | 0.00 | 12,136 | 0 | 64,660 | 52.5 K to 64.7 K (+23.11 %) |
Feb 07 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 109.14 | 3,594 | 392,249 | 14,375 | |
Feb 07 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 164.71 | 100 | 16,471 | 52,524 | 52.6 K to 52.5 K (-0.19 %) |
Feb 07 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 164.12 | 900 | 147,708 | 52,624 | 53.5 K to 52.6 K (-1.68 %) |
Feb 07 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 162.94 | 400 | 65,176 | 53,524 | 53.9 K to 53.5 K (-0.74 %) |
Feb 07 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 161.51 | 500 | 80,755 | 53,924 | 54.4 K to 53.9 K (-0.92 %) |
Feb 07 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 160.50 | 500 | 80,250 | 54,424 | 54.9 K to 54.4 K (-0.91 %) |
Feb 07 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 159.62 | 700 | 111,734 | 54,924 | 55.6 K to 54.9 K (-1.26 %) |
Feb 07 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 158.32 | 494 | 78,210 | 55,624 | 56.1 K to 55.6 K (-0.88 %) |
Feb 07 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 109.14 | 3,594 | 392,249 | 56,118 | 52.5 K to 56.1 K (+6.84 %) |
Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 91.05 | 1,796 | 163,526 | 14,368 | |
Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 91.05 | 1,796 | 163,526 | 14,368 | |
Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 169.49 | 100 | 16,949 | 52,524 | 52.6 K to 52.5 K (-0.19 %) |
Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 169.49 | 100 | 16,949 | 52,524 | 52.6 K to 52.5 K (-0.19 %) |
Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 168.06 | 100 | 16,806 | 52,624 | 52.7 K to 52.6 K (-0.19 %) |
Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 168.06 | 100 | 16,806 | 52,624 | 52.7 K to 52.6 K (-0.19 %) |
Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 166.10 | 996 | 165,436 | 52,724 | 53.7 K to 52.7 K (-1.85 %) |
Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 166.10 | 996 | 165,436 | 52,724 | 53.7 K to 52.7 K (-1.85 %) |
Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 165.23 | 600 | 99,138 | 53,720 | 54.3 K to 53.7 K (-1.10 %) |
Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 165.23 | 600 | 99,138 | 53,720 | 54.3 K to 53.7 K (-1.10 %) |
Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 91.05 | 1,796 | 163,526 | 54,320 | 52.5 K to 54.3 K (+3.42 %) |
Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 91.05 | 1,796 | 163,526 | 54,320 | 52.5 K to 54.3 K (+3.42 %) |
Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 167.44 | 1,900 | 318,136 | 52,524 | 54.4 K to 52.5 K (-3.49 %) |
Feb 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 167.44 | 1,900 | 318,136 | 52,524 | 54.4 K to 52.5 K (-3.49 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 96.87 | 1,719 | 166,520 | 3,438 | |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 159.04 | 300 | 47,712 | 54,424 | 54.7 K to 54.4 K (-0.55 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 157.54 | 900 | 141,786 | 54,724 | 55.6 K to 54.7 K (-1.62 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 155.80 | 519 | 80,860 | 55,624 | 56.1 K to 55.6 K (-0.92 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 96.87 | 1,719 | 166,520 | 56,143 | 54.4 K to 56.1 K (+3.16 %) |
Jan 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 73.51 | 3,438 | 252,727 | 0 | |
Jan 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 152.80 | 863 | 131,866 | 54,424 | 55.3 K to 54.4 K (-1.56 %) |
Jan 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 152.06 | 1,600 | 243,296 | 55,287 | 56.9 K to 55.3 K (-2.81 %) |
Jan 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 150.87 | 675 | 101,837 | 56,887 | 57.6 K to 56.9 K (-1.17 %) |
Jan 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 149.65 | 300 | 44,895 | 57,562 | 57.9 K to 57.6 K (-0.52 %) |
Jan 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 73.51 | 3,438 | 252,727 | 57,862 | 54.4 K to 57.9 K (+6.32 %) |
Nov 06 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 109.14 | 3,594 | 392,249 | 17,969 | |
Nov 06 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 91.05 | 1,796 | 163,526 | 16,164 | |
Nov 06 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 144.69 | 3,594 | 520,016 | 54,424 | 58 K to 54.4 K (-6.19 %) |
Nov 06 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 109.14 | 3,594 | 392,249 | 58,018 | 54.4 K to 58 K (+6.60 %) |
Nov 06 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 145.89 | 300 | 43,767 | 54,424 | 54.7 K to 54.4 K (-0.55 %) |
Nov 06 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 144.89 | 1,096 | 158,799 | 54,724 | 55.8 K to 54.7 K (-1.96 %) |
Nov 06 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 143.54 | 400 | 57,416 | 55,820 | 56.2 K to 55.8 K (-0.71 %) |
Nov 06 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 91.05 | 1,796 | 163,526 | 56,220 | 54.4 K to 56.2 K (+3.30 %) |
Oct 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 149.34 | 200 | 29,868 | 54,424 | 54.6 K to 54.4 K (-0.37 %) |
Oct 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 148.40 | 1,400 | 207,760 | 54,624 | 56 K to 54.6 K (-2.50 %) |
Oct 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 147.75 | 3,400 | 502,350 | 56,024 | 59.4 K to 56 K (-5.72 %) |
Oct 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 146.52 | 4,700 | 688,644 | 59,424 | 64.1 K to 59.4 K (-7.33 %) |
Oct 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 145.26 | 19,016 | 2,762,264 | 64,124 | 83.1 K to 64.1 K (-22.87 %) |
Oct 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 144.46 | 25,784 | 3,724,757 | 83,140 | 108.9 K to 83.1 K (-23.67 %) |
Oct 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 143.46 | 4,100 | 588,186 | 108,924 | 113 K to 108.9 K (-3.63 %) |
Oct 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 142.38 | 1,400 | 199,332 | 113,024 | 114.4 K to 113 K (-1.22 %) |
Oct 18 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 96.87 | 1,718 | 166,423 | 5,157 | |
Oct 18 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 157.38 | 300 | 47,214 | 114,424 | 114.7 K to 114.4 K (-0.26 %) |
Oct 18 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 155.92 | 300 | 46,776 | 114,724 | 115 K to 114.7 K (-0.26 %) |
Oct 18 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 154.76 | 818 | 126,594 | 115,024 | 115.8 K to 115 K (-0.71 %) |
Oct 18 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 153.42 | 300 | 46,026 | 115,842 | 116.1 K to 115.8 K (-0.26 %) |
Oct 18 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 96.87 | 1,718 | 166,423 | 116,142 | 114.4 K to 116.1 K (+1.50 %) |
Oct 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 73.51 | 3,437 | 252,654 | 3,438 | |
Oct 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 152.62 | 600 | 91,572 | 114,424 | 115 K to 114.4 K (-0.52 %) |
Oct 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 151.82 | 1,443 | 219,076 | 115,024 | 116.5 K to 115 K (-1.24 %) |
Oct 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 151.04 | 1,394 | 210,550 | 116,467 | 117.9 K to 116.5 K (-1.18 %) |
Oct 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 73.51 | 3,437 | 252,654 | 117,861 | 114.4 K to 117.9 K (+3.00 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 109.14 | 3,594 | 392,249 | 21,563 | |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 91.05 | 1,796 | 163,526 | 17,960 | |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 155.15 | 500 | 77,575 | 114,424 | 114.9 K to 114.4 K (-0.44 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 154.21 | 2,494 | 384,600 | 114,924 | 117.4 K to 114.9 K (-2.12 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 153.29 | 600 | 91,974 | 117,418 | 118 K to 117.4 K (-0.51 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 109.14 | 3,594 | 392,249 | 118,018 | 114.4 K to 118 K (+3.14 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 156.24 | 296 | 46,247 | 114,424 | 114.7 K to 114.4 K (-0.26 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 154.89 | 400 | 61,956 | 114,720 | 115.1 K to 114.7 K (-0.35 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 153.93 | 600 | 92,358 | 115,120 | 115.7 K to 115.1 K (-0.52 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 152.50 | 500 | 76,250 | 115,720 | 116.2 K to 115.7 K (-0.43 %) |
Aug 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 91.05 | 1,796 | 163,526 | 116,220 | 114.4 K to 116.2 K (+1.57 %) |
Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 109.14 | 32,343 | 3,529,915 | 25,157 | |
Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 96.87 | 6,303 | 610,572 | 6,875 | |
Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 162.04 | 1,336 | 216,485 | 114,424 | 115.8 K to 114.4 K (-1.15 %) |
Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 161.38 | 3,464 | 559,020 | 115,760 | 119.2 K to 115.8 K (-2.91 %) |
Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 159.85 | 400 | 63,940 | 119,224 | 119.6 K to 119.2 K (-0.33 %) |
Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 158.92 | 1,000 | 158,920 | 119,624 | 120.6 K to 119.6 K (-0.83 %) |
Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 158.08 | 700 | 110,656 | 120,624 | 121.3 K to 120.6 K (-0.58 %) |
Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 161.00 | 39,833 | 6,413,113 | 121,324 | 161.2 K to 121.3 K (-24.72 %) |
Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 109.14 | 32,343 | 3,529,915 | 161,157 | 128.8 K to 161.2 K (+25.11 %) |
Jul 21 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 96.87 | 6,303 | 610,572 | 128,814 | 122.5 K to 128.8 K (+5.14 %) |
Jul 19 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 96.87 | 573 | 55,507 | 13,178 | |
Jul 19 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 130.96 | 100 | 13,096 | 122,511 | 122.6 K to 122.5 K (-0.08 %) |
Jul 19 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 129.61 | 473 | 61,306 | 122,611 | 123.1 K to 122.6 K (-0.38 %) |
Jul 19 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 96.87 | 573 | 55,507 | 123,084 | 122.5 K to 123.1 K (+0.47 %) |
Jul 06 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 73.51 | 3,438 | 252,727 | 6,875 | |
Jul 06 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 128.57 | 1,216 | 156,341 | 122,511 | 123.7 K to 122.5 K (-0.98 %) |
Jul 06 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 127.38 | 2,222 | 283,038 | 123,727 | 125.9 K to 123.7 K (-1.76 %) |
Jul 06 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 73.51 | 3,438 | 252,727 | 125,949 | 122.5 K to 125.9 K (+2.81 %) |
Jun 23 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 96.87 | 5,157 | 499,559 | 8,594 | |
Jun 23 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 132.87 | 5,157 | 685,211 | 122,511 | 127.7 K to 122.5 K (-4.04 %) |
Jun 23 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 96.87 | 5,157 | 499,559 | 127,668 | 122.5 K to 127.7 K (+4.21 %) |
Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 96.87 | 5,155 | 499,365 | 18,908 | |
Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 126.87 | 5,155 | 654,015 | 122,511 | 127.7 K to 122.5 K (-4.04 %) |
Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 96.87 | 5,155 | 499,365 | 127,666 | 122.5 K to 127.7 K (+4.21 %) |
May 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 91.05 | 8,979 | 817,538 | 19,756 | |
May 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 121.05 | 8,979 | 1,086,908 | 122,511 | 131.5 K to 122.5 K (-6.83 %) |
May 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 91.05 | 8,979 | 817,538 | 131,490 | 122.5 K to 131.5 K (+7.33 %) |
Apr 07 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 73.51 | 8,021 | 589,624 | 10,313 | |
Apr 07 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 114.00 | 8,021 | 914,394 | 122,511 | 130.5 K to 122.5 K (-6.14 %) |
Apr 07 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 73.51 | 8,021 | 589,624 | 130,532 | 122.5 K to 130.5 K (+6.55 %) |
Apr 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 73.51 | 2,291 | 168,411 | 18,334 | |
Apr 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 73.51 | 2,291 | 168,411 | 18,334 | |
Apr 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 110.09 | 200 | 22,018 | 122,511 | 122.7 K to 122.5 K (-0.16 %) |
Apr 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 110.09 | 200 | 22,018 | 122,511 | 122.7 K to 122.5 K (-0.16 %) |
Apr 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 109.32 | 600 | 65,592 | 122,711 | 123.3 K to 122.7 K (-0.49 %) |
Apr 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 109.32 | 600 | 65,592 | 122,711 | 123.3 K to 122.7 K (-0.49 %) |
Apr 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 108.50 | 1,491 | 161,774 | 123,311 | 124.8 K to 123.3 K (-1.19 %) |
Apr 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 108.50 | 1,491 | 161,774 | 123,311 | 124.8 K to 123.3 K (-1.19 %) |
Apr 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 73.51 | 2,291 | 168,411 | 124,802 | 122.5 K to 124.8 K (+1.87 %) |
Apr 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 73.51 | 2,291 | 168,411 | 124,802 | 122.5 K to 124.8 K (+1.87 %) |
Mar 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 73.51 | 13,750 | 1,010,763 | 20,625 | |
Mar 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 106.65 | 13,750 | 1,466,438 | 122,511 | 136.3 K to 122.5 K (-10.09 %) |
Mar 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 73.51 | 13,750 | 1,010,763 | 136,261 | 122.5 K to 136.3 K (+11.22 %) |
Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | A | 86.52 | 24,852 | 2,150,195 | 24,852 | |
Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Grant | A | 0.00 | 12,136 | 0 | 127,633 | 115.5 K to 127.6 K (+10.51 %) |
Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Grant | A | 0.01 | 4,794 | 48 | 115,497 | 110.7 K to 115.5 K (+4.33 %) |
Feb 03 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 85.91 | 1,500 | 128,865 | 110,703 | 112.2 K to 110.7 K (-1.34 %) |
Feb 03 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 85.08 | 400 | 34,032 | 112,203 | 112.6 K to 112.2 K (-0.36 %) |
Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | A | 91.05 | 28,735 | 2,616,322 | 28,735 | |
Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 91.80 | 1,275 | 117,045 | 112,603 | 113.9 K to 112.6 K (-1.12 %) |
Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 90.89 | 1,100 | 99,979 | 113,878 | 115 K to 113.9 K (-0.96 %) |
Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Grant | A | 0.01 | 14,416 | 144 | 114,978 | 100.6 K to 115 K (+14.34 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 73.51 | 10,315 | 758,256 | 30,938 | |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 130.00 | 10,315 | 1,340,950 | 100,562 | 110.9 K to 100.6 K (-9.30 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 73.51 | 10,315 | 758,256 | 110,877 | 100.6 K to 110.9 K (+10.26 %) |
Jul 23 2015 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | A | 131.89 | 34,000 | 4,484,260 | 34,000 | |
Jul 07 2015 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 73.51 | 2,291 | 168,411 | 41,253 | |
Jul 07 2015 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 130.63 | 1,297 | 169,427 | 100,562 | 101.9 K to 100.6 K (-1.27 %) |
Jul 07 2015 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 129.54 | 100 | 12,954 | 101,859 | 102 K to 101.9 K (-0.10 %) |
Jul 07 2015 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 128.12 | 500 | 64,060 | 101,959 | 102.5 K to 102 K (-0.49 %) |
Jul 07 2015 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 126.69 | 394 | 49,916 | 102,459 | 102.9 K to 102.5 K (-0.38 %) |
Jul 07 2015 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 73.51 | 2,291 | 168,411 | 102,853 | 100.6 K to 102.9 K (+2.28 %) |
Apr 06 2015 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 73.51 | 2,291 | 168,411 | 43,544 | |
Apr 06 2015 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 116.70 | 545 | 63,602 | 100,562 | 101.1 K to 100.6 K (-0.54 %) |
Apr 06 2015 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 115.12 | 1,746 | 201,000 | 101,107 | 102.9 K to 101.1 K (-1.70 %) |
Apr 06 2015 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 73.51 | 2,291 | 168,411 | 102,853 | 100.6 K to 102.9 K (+2.28 %) |
Page: 1